Dan Wei
16766 Jingshi Road
Jinan, 250014, China
Jinan, 250014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
BANF1 knockdown impedes thyroid cancer development and boosts CD8+ T cell activity through PI3K/AKT/mTOR pathway.
Journal: American journal of cancer research
Published: January 29, 2026
Network toxicology and single-cell transcriptomics nominate candidate pyrethroid-associated targets and pathways in clear cell renal cell carcinoma.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 19, 2026
Calcitonin-negative medullary thyroid carcinoma combined with multifocal papillary thyroid carcinoma: a case report and literature review.
Journal: BMC endocrine disorders
Published: September 27, 2025
Cyclic Cushing syndrome associated with cadherin-23 and multiple endocrine neoplasia type 1 gene mutations accompanied by bilateral primary papillary thyroid carcinoma.
Journal: Polish archives of internal medicine
Published: July 04, 2025
Engineered molybdenum disulfide nanosheets as scavengers against oxidative stress inhibit ferroptosis to alleviate acute kidney injury.
Journal: Nanoscale
Published: February 26, 2025
Efficient generation of octave-separating orbital angular momentum beams via forked grating array in lithium niobite crystal.
Journal: Nanophotonics (Berlin, Germany)
Published: March 30, 2024
CXCR4 promotes migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma by activating STAT3 signaling pathway.
Journal: Journal of cancer research and therapeutics
Published: November 13, 2023
Single-cell RNA-sequencing analysis reveals MYH9 promotes renal cell carcinoma development and sunitinib resistance via AKT signaling pathway.
Journal: Cell death discovery
Published: December 11, 2021
Disordered serum essential element levels are associated with increased risk of kidney tumors.
Journal: Environmental science and pollution research international
Published: September 19, 2021
Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy.
Journal: Yonsei medical journal
Published: August 24, 2021
Theobromine ameliorates nonalcoholic fatty liver disease by regulating hepatic lipid metabolism via mTOR signaling pathway in vivo and in vitro.
Journal: Canadian journal of physiology and pharmacology
Published: December 08, 2020
Last Updated: 09/26/2026